Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure

William T. Birdsong, Seksiri Arttamangkul, Mary J. Clark, Kejun Cheng, Kenner C. Rice, John R. Traynor, John Williams

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Prolonged exposure to high-efficacy agonists results in desensitization of the μ-opioid receptor (MOR). Desensitized receptors are thought to be unable to couple to G-proteins, preventing downstream signaling; however, the changes to the receptor itself are not well characterized. In the current study, confocal imaging was used to determine whether desensitizing conditions cause a change in agonist-receptor interactions. Using rapid solution exchange, the binding kinetics of fluorescently labeled opioid agonist, dermorphin Alexa594 (derm A594), to MORs was measured in live cells. The affinity of derm A594 binding increased after prolonged treatment of cells with multiple agonists that are known to cause receptor desensitization. In contrast, binding of a fluorescent antagonist, naltrexamine Alexa594, was unaffected by similar agonist pretreatment. The increased affinity of derm A594 for the receptor was long-lived and partially reversed after a 45 min wash. Treatment of the cells with pertussis toxin did not alter the increase in affinity of the derm A594 for MOR. Likewise, the affinity of derm A594 for MORs expressed in mouse embryonic fibroblasts derived from arrestin 1 and 2 knock-out animals increased after treatment of the cells with the desensitization protocol. Thus, opioid receptors were "imprinted" with a memory of prior agonist exposure that was independent of G-protein activation or arrestin binding that altered subsequent agonist-receptor interactions. The increased affinity suggests that acute desensitization results in a long-lasting but reversible conformational change in the receptor.

Original languageEnglish (US)
Pages (from-to)4118-4127
Number of pages10
JournalJournal of Neuroscience
Volume33
Issue number9
DOIs
StatePublished - Feb 27 2013

Fingerprint

Opioid Receptors
GTP-Binding Proteins
Arrestin
Pertussis Toxin
Opioid Analgesics
Alexa594
Fibroblasts
dermorphin
Psychologic Desensitization

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure. / Birdsong, William T.; Arttamangkul, Seksiri; Clark, Mary J.; Cheng, Kejun; Rice, Kenner C.; Traynor, John R.; Williams, John.

In: Journal of Neuroscience, Vol. 33, No. 9, 27.02.2013, p. 4118-4127.

Research output: Contribution to journalArticle

Birdsong, William T. ; Arttamangkul, Seksiri ; Clark, Mary J. ; Cheng, Kejun ; Rice, Kenner C. ; Traynor, John R. ; Williams, John. / Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure. In: Journal of Neuroscience. 2013 ; Vol. 33, No. 9. pp. 4118-4127.
@article{8ea6bef6d80b4baaba28fa40b37e5192,
title = "Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure",
abstract = "Prolonged exposure to high-efficacy agonists results in desensitization of the μ-opioid receptor (MOR). Desensitized receptors are thought to be unable to couple to G-proteins, preventing downstream signaling; however, the changes to the receptor itself are not well characterized. In the current study, confocal imaging was used to determine whether desensitizing conditions cause a change in agonist-receptor interactions. Using rapid solution exchange, the binding kinetics of fluorescently labeled opioid agonist, dermorphin Alexa594 (derm A594), to MORs was measured in live cells. The affinity of derm A594 binding increased after prolonged treatment of cells with multiple agonists that are known to cause receptor desensitization. In contrast, binding of a fluorescent antagonist, naltrexamine Alexa594, was unaffected by similar agonist pretreatment. The increased affinity of derm A594 for the receptor was long-lived and partially reversed after a 45 min wash. Treatment of the cells with pertussis toxin did not alter the increase in affinity of the derm A594 for MOR. Likewise, the affinity of derm A594 for MORs expressed in mouse embryonic fibroblasts derived from arrestin 1 and 2 knock-out animals increased after treatment of the cells with the desensitization protocol. Thus, opioid receptors were {"}imprinted{"} with a memory of prior agonist exposure that was independent of G-protein activation or arrestin binding that altered subsequent agonist-receptor interactions. The increased affinity suggests that acute desensitization results in a long-lasting but reversible conformational change in the receptor.",
author = "Birdsong, {William T.} and Seksiri Arttamangkul and Clark, {Mary J.} and Kejun Cheng and Rice, {Kenner C.} and Traynor, {John R.} and John Williams",
year = "2013",
month = "2",
day = "27",
doi = "10.1523/JNEUROSCI.4187-12.2013",
language = "English (US)",
volume = "33",
pages = "4118--4127",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "9",

}

TY - JOUR

T1 - Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure

AU - Birdsong, William T.

AU - Arttamangkul, Seksiri

AU - Clark, Mary J.

AU - Cheng, Kejun

AU - Rice, Kenner C.

AU - Traynor, John R.

AU - Williams, John

PY - 2013/2/27

Y1 - 2013/2/27

N2 - Prolonged exposure to high-efficacy agonists results in desensitization of the μ-opioid receptor (MOR). Desensitized receptors are thought to be unable to couple to G-proteins, preventing downstream signaling; however, the changes to the receptor itself are not well characterized. In the current study, confocal imaging was used to determine whether desensitizing conditions cause a change in agonist-receptor interactions. Using rapid solution exchange, the binding kinetics of fluorescently labeled opioid agonist, dermorphin Alexa594 (derm A594), to MORs was measured in live cells. The affinity of derm A594 binding increased after prolonged treatment of cells with multiple agonists that are known to cause receptor desensitization. In contrast, binding of a fluorescent antagonist, naltrexamine Alexa594, was unaffected by similar agonist pretreatment. The increased affinity of derm A594 for the receptor was long-lived and partially reversed after a 45 min wash. Treatment of the cells with pertussis toxin did not alter the increase in affinity of the derm A594 for MOR. Likewise, the affinity of derm A594 for MORs expressed in mouse embryonic fibroblasts derived from arrestin 1 and 2 knock-out animals increased after treatment of the cells with the desensitization protocol. Thus, opioid receptors were "imprinted" with a memory of prior agonist exposure that was independent of G-protein activation or arrestin binding that altered subsequent agonist-receptor interactions. The increased affinity suggests that acute desensitization results in a long-lasting but reversible conformational change in the receptor.

AB - Prolonged exposure to high-efficacy agonists results in desensitization of the μ-opioid receptor (MOR). Desensitized receptors are thought to be unable to couple to G-proteins, preventing downstream signaling; however, the changes to the receptor itself are not well characterized. In the current study, confocal imaging was used to determine whether desensitizing conditions cause a change in agonist-receptor interactions. Using rapid solution exchange, the binding kinetics of fluorescently labeled opioid agonist, dermorphin Alexa594 (derm A594), to MORs was measured in live cells. The affinity of derm A594 binding increased after prolonged treatment of cells with multiple agonists that are known to cause receptor desensitization. In contrast, binding of a fluorescent antagonist, naltrexamine Alexa594, was unaffected by similar agonist pretreatment. The increased affinity of derm A594 for the receptor was long-lived and partially reversed after a 45 min wash. Treatment of the cells with pertussis toxin did not alter the increase in affinity of the derm A594 for MOR. Likewise, the affinity of derm A594 for MORs expressed in mouse embryonic fibroblasts derived from arrestin 1 and 2 knock-out animals increased after treatment of the cells with the desensitization protocol. Thus, opioid receptors were "imprinted" with a memory of prior agonist exposure that was independent of G-protein activation or arrestin binding that altered subsequent agonist-receptor interactions. The increased affinity suggests that acute desensitization results in a long-lasting but reversible conformational change in the receptor.

UR - http://www.scopus.com/inward/record.url?scp=84874597038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874597038&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4187-12.2013

DO - 10.1523/JNEUROSCI.4187-12.2013

M3 - Article

VL - 33

SP - 4118

EP - 4127

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 9

ER -